ClinicalTrials.gov record
Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients
COMPLETED · NCT03972527
Trial record
NCT IDNCT03972527
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
NA
Enrollment
85
Conditions
Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Radiation, Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy, Head and Neck Cancer
Interventions
Photobiomodulation, Routine Oral Care and Analgesia
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States, The Oncology Institute, Long Beach, California, United States, Miami Cancer Institute, Miami, Florida, United States, St. Elizabeth Healthcare, Edgewood, Kentucky, United States, Willis-Knighton Cancer Center, Shreveport, Louisiana, United States, University of Mississippi Medical Center, Jackson, Mississippi, United States, Erie County Medical Center, Buffalo, New York, United States, NYU Langone, New York, New York, United States
Indexed topics
Last update
2024-08-19